Does kefir help with weight loss?

No, on the trials that exist. A 2023 meta-analysis of 6 randomized trials in 314 people found kefir did not change body weight (p = 0.439), and a 2026 meta-analysis of 24 kefir intervention studies found no significant effect on body measures. The one trial built to ask the question directly, in 75 overweight or obese women over 8 weeks, found kefir did no better than the same amount of low-fat milk.

Myth. Kefir is not a weight-loss food. Two meta-analyses looked and found no effect on weight, and the trial that compared it with plain milk found no difference between the two. Neither review publishes a pooled weight number or a confidence interval in its abstract, so we cannot tell you how close to zero the effect sits.

What the trials found

Kefir itself

The 2023 review pooled six small randomized trials published up to June 2021. Weight did not move. What did move was insulin resistance: fasting insulin fell by 3.69 micro-IU/mL (95% CI 1.07 to 6.30) and the HOMA-IR score by 2.56 (1.30 to 3.82). The authors still found no effect on fasting glucose, HbA1c or blood lipids. The 2026 review, of 24 intervention studies, reached the same answer on body measures, lipids and inflammation. Its abstract gives no pooled weight figure and does not say every study was randomized, and we could not read the full text.

The weight trial in Iran gave overweight or obese women aged 25 to 45 two extra dairy servings a day for 8 weeks, without asking them to eat less. One group drank kefir and one drank low-fat milk. There was no significant difference between them. Only 58 of the 75 women finished. Because the milk group got the same amount of extra dairy, this is the comparison that tests the cultures, and they added nothing measurable.

Appetite

The idea that kefir keeps you fuller has been tested twice. In a 3-week crossover trial, 28 overweight adults drank kefir and then milk, and appetite was unaffected by either. Blood lipids and glucose improved to a similar degree on both drinks. In 67 overweight or obese men over 65, kefir with two extra bacterial strains made no difference to appetite compared with ordinary kefir over 8 weeks. That second trial compared kefir with kefir, so it cannot say anything about kefir against no kefir.

Probiotics as a class

The live-culture argument borrows from probiotic supplement trials. A 2026 meta-analysis of 12 randomized trials in overweight and obese adults, mostly from East Asia, found weight fell by 0.52 (95% CI 0.13 to 0.90) against placebo, a unit the abstract does not label and most likely kilograms. Body fat percentage fell by 0.59 points. An earlier review of 15 trials in 957 adults found the change in fat mass was not significant, at 0.93 lb (0.42 kg) with an interval running from a loss of 1.08 to a gain of 0.23. These are capsules and powders with chosen strains at chosen doses. Kefir was not in them.

Observational data link eating more yogurt with 21 percent lower odds of abdominal obesity, across 9 studies and 47,778 adults. Most of those studies were cross-sectional snapshots. People who eat yogurt differ in other ways, and kefir was not counted separately.

Unsettled. A small benefit cannot be ruled out, because neither kefir review publishes its pooled weight estimate with an interval. What can be said is that nobody has shown one, and the direct comparison with milk came out level.

Who should be careful

Kefir is fermented milk, so anyone with a milk allergy should treat it as milk. The one safety trial in sick adults gave up to 8.1 fl oz (240 mL) a day to 54 critically ill patients in intensive care, and no bloodstream infections, fungal infections or deaths were linked to kefir. Two patients had diarrhea while also taking laxatives. Patients took kefir for a short time, a median of about 3 days, and there was no comparison group. That trial also shut out four groups: people on immunosuppressants for a month or longer, people with dairy intolerance or milk allergy, people whose gut lining was compromised, and pregnant women. Live-culture safety has not been tested in any of them.

Not for everyone. If your immune system is suppressed by medicine or illness, or you are pregnant, kefir's safety has not been studied in people like you. That is a gap in the evidence rather than a finding of harm, and it is a question for the person treating you. A scoping review of 44 human studies judged kefir safe for people without serious illness.

What expert bodies say

The European Union refused the health claim that dairy in an energy-restricted diet helps weight loss. That claim covered cow's milk, yogurt and cheese. Kefir was not named in it. The EU register holds no claim of any kind that names kefir.

How we searched

What would change this answer

• A kefir meta-analysis that publishes its pooled weight difference with a confidence interval. Today we know the result was not significant, and we do not know how close it came.
• A longer randomized trial against a dairy drink matched for energy, so that any difference could be put down to the fermentation and its cultures.
• A registered trial of a kefir peptide powder in children, with BMI as the main outcome, was still enrolling when we checked. It tests a supplement made from kefir, so even a positive result would not answer the question about the drink.

More on the food itself: Kefir: what the trials measured →

Sources

1. ev-kefw-01 · Meta-analysis or systematic review · systematic review and meta-analysis of interventional studies, subgroups by kefir dose · n = 24 studies
   However, no significant effects were observed on anthropometric measures, lipid profile, or inflammatory markers.
   
   Who: adults in 24 interventional studies identified from 702 articles, searched to January 2025
   Effect: anthropometric measures, lipid profile and inflammatory markers not significant
   Certainty: Abstract gives no pooled weight estimate or confidence interval and does not say all studies were randomized; no full text in PMC (no_pmc).
   Nutr Metab Cardiovasc Dis, 2026 · checked 2026-10-07 · we read the abstract
2. ev-kefw-02 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs, random effects · n = 314
   Kefir has a beneficial effect in decreasing insulin resistance; however, no effect was seen on BW, FBS, HbA1C, and lipid profile.
   
   Who: 314 subjects in six randomized controlled trials published to June 2021
   Effect: body weight not significant (p = 0.439); fasting insulin WMD -3.69 micro-IU/mL (95% CI -6.30 to -1.07); HOMA-IR WMD -2.56 (-3.82 to -1.30)
   Certainty: Six small trials; pooled weight difference and CI not given in the abstract, only the p value.
   Current Drug Targets, 2023, 24(7):599-612 (Yahyapoor et al.) · checked 2026-10-07 · we read the abstract
3. ev-kefw-03 · Randomized controlled trial(s) · single-center multi-arm parallel-group randomized controlled trial, 8 weeks · n = 75
   However, no such significant differences were found between the kefir and milk groups.
   
   Who: overweight or obese premenopausal women aged 25-45 years, Iran, intention-to-treat
   Effect: kefir vs milk not significant
   Certainty: 58 of 75 completed; the comparison with an equal amount of milk tests the cultures, and they added nothing significant.
   Eur J Nutr, 2016 · checked 2026-10-07 · we read the abstract
4. ev-kefw-04 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = 957
   The effect of probiotics on fat mass was non-significant (-0.42 [-1.08, 0.23] kg, I2 = 84%).
   
   Who: adults with overweight or obesity, mean BMI 27.6, 63% women, 15 RCTs
   Effect: fat mass -0.93 lb (95% CI -2.4 to 0.51, I2 84%; metric: -0.42 kg, -1.08 to 0.23), not significant
   Certainty: Probiotics as a class, mostly capsules and powders, not kefir; effect sizes small by the authors' own account.
   Obes Rev, 2018 · checked 2026-10-07 · we read the abstract
5. ev-kefw-05 · Meta-analysis or systematic review · meta-analysis of randomized controlled trials, Cochrane RoB 1.0 · n = 12 RCTs
   A meta-analysis of 12 randomized controlled trials demonstrated that probiotics effectively improve body weight (MD = -0.52, 95% CI - 0.90 to -0.13, p < 0.01), BMI (MD = -0.22, 95% CI - 0.34 to -0.11, p < 0.01), waist circumference (MD = -0.29, 95% CI - 0.56 to -0.02, p = 0.03), and body fat percentage (MD = -0.59, 95% CI - 0.96 to -0.21, p < 0.01) in obese patients, but it has no significant effect on total cholesterol (MD = -2.94, 95% CI - 6.05 to 0.17, p = 0.06) and triglycerides (MD = -6.77, 95% CI (-14.58 to 1.05, p = 0.09).
   
   Who: overweight and obese adults in 12 randomized controlled trials, searched to August 2025
   Effect: body weight MD -0.52 (95% CI -0.90 to -0.13); BMI MD -0.22 (-0.34 to -0.11); waist MD -0.29 (-0.56 to -0.02)
   Certainty: Probiotic supplements, not kefir; strain-specific; weight unit not stated in the abstract, assumed kg.
   Front Public Health, 2026 · checked 2026-10-07 · we read the abstract
6. ev-kefw-06 · Randomized controlled trial(s) · crossover intervention study, 3 weeks kefir vs 3 weeks milk · n = 28
   The C-reactive protein, adiponectin, and appetite were unaffected.
   
   Who: asymptomatic overweight adults
   Effect: appetite, CRP and adiponectin unaffected; lipid profile and glucose improved similarly with kefir and milk; zonulin improved more with kefir
   Certainty: Short, small; abstract gives no anthropometric result although it was measured.
   J Dairy Sci, 2020 · checked 2026-10-07 · we read the abstract
7. ev-kefw-07 · Randomized controlled trial(s) · randomized double-blind placebo-controlled trial, 8 weeks · n = 67
   However, when comparing the two groups, no significant effects were observed on appetite, inflammation, and oxidative stress parameters, except for TAC.
   
   Who: overweight and obese elderly men aged over 65, Iran, 35 regular kefir vs 32 probiotic-fortified kefir, 240 cc a day
   Effect: appetite not different between groups (within-group appetite rose in both, p < 0.05); depression scores better with fortified kefir (p = 0.001)
   Certainty: Comparator was ordinary kefir, so this tests added strains, not kefir itself; weight not reported in the abstract.
   J Health Popul Nutr, 2025 · checked 2026-10-07 · we read the abstract
8. ev-kefw-08 · Observational data · systematic review and dose-response meta-analysis of observational studies, GRADE · n = 47,778
   Pooling effect sizes from 9 eligible studies with 47 778 participants showed that higher amounts of yogurt consumption was related to a 21% reduction in abdominal obesity (OR = 0.79; 95% CI, 0.70-0.89).
   
   Who: adults in 9 observational studies on yogurt, within 28 cohort and cross-sectional studies
   Effect: yogurt highest vs lowest OR 0.79 (95% CI 0.70 to 0.89) for abdominal obesity
   Certainty: Mostly cross-sectional; association not cause; yogurt, not kefir; OR is odds, not risk.
   Nutr Rev, 2026 · checked 2026-10-07 · we read the abstract
9. ev-kefw-09 · Observational data · open-label phase I safety and feasibility study, Methods, NCT05416814 · n = 54
   (iii) dairy intolerance or milk allergies; (iv) an extremely poor prognosis where survival through the treatment period was unlikely; and (v) pregnancy.
   
   Who: exclusion criteria of an ICU kefir phase I study
   Effect: excluded: immunosuppression of at least 1 month, compromised gut integrity, dairy intolerance or milk allergy, pregnancy
   Certainty: An exclusion list, not a finding of harm. Kefir is a milk product, so milk allergy applies.
   BMC Med, 2024 · checked 2026-10-07 · we read the fulltext
10. ev-kefw-10 · Observational data · open-label phase I safety and feasibility study, escalating dose 2 to 8.1 fl oz (60 to 240 mL) daily · n = 54
    Importantly, no cases of bacteremia, fungemia, or deaths were associated with kefir.
    
    Who: critically ill adults in the ICU with an intact gastrointestinal tract
    Effect: 0 bacteremia, fungemia or deaths linked to kefir; diarrhea in 2 patients on concurrent laxatives
    Certainty: No control arm; median exposure about 3 days.
    BMC Med, 2024 · checked 2026-10-07 · we read the fulltext
11. ev-kefw-11 · Observational data · scoping review, Joanna Briggs Institute guidelines · n = 44 studies
    The studies showed that kefir is safe for people without serious illnesses.
    
    Who: 44 clinical studies of kefir-fermented milk in humans, searched to March 2022
    Effect: no standard therapeutic dose or treatment time established; safe in people without serious illnesses
    Certainty: Scoping review, no pooling or formal risk-of-bias grading.
    Nutr Res Rev, 2024 · checked 2026-10-07 · we read the abstract
12. ev-kefw-12 · Position of an expert body · regulatory decision, EU Register on nutrition and health claims · n = 1 claim
    POL-HC-7009 Dairy (low fat dairy) *Dairy refers to cow’s milk, yogurt and cheese Dairy in an energy restricted diet helps weight loss. Consuming dairy foods, as part of your weight loss diet, will help weight loss. Consuming dairy foods, as part of your weight loss diet, will help weight maintenance. Non-authorised
    
    Who: EU market, Article 13 claim for low-fat dairy (cow's milk, yogurt and cheese)
    Effect: status Non-authorized; search for 'kefir' in the register returned nothing
    Certainty: Claim covers dairy in general; kefir would fall under it as a fermented milk.
    EU Register on nutrition and health claims, claim POL-HC-7009, snapshot 2026-09-21 · checked 2026-10-07 · we read the dataset